Hitesh Patel - Concepedia

Author

Hitesh Patel

Edinburgh Cancer Research

Also Known As

Hitesh K Patel, Hitesh K. Patel, Hitesh Kumar A. Patel, Hitesh PATEL, Hitesh Patel, Patel, Hitesh, Walter F. Stafford

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Edinburgh Cancer Research Cancer Research UK Scotland Institute Royal Veterinary College University of Edinburgh University of London

About

Hitesh Patel is an author at Edinburgh Cancer Research specializing in medicine, natural sciences, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	5.1K
2	Natural Sciences	10	10	610
3	Engineering	3	3	69
4	Health Sciences	1	1	102
5	Law	1	1	37

Hitesh Patel

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
A quantitative analysis of kinase inhibitor selectivity Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber, Nature Biotechnology Drug TargetSignal TransductionMedicineReceptor Tyrosine KinaseKinase Inhibitor Selectivity	2008	2.4K
A small molecule–kinase interaction map for clinical kinase inhibitors Miles A. Fabian, William Biggs, Daniel K. Treiber, Nature Biotechnology Molecular DockingDrug TargetClinical Kinase InhibitorsMedicinePharmacology	2005	1.9K
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML) Patrick P. Zarrinkar, Ruwanthi N. Gunawardane, Merryl Cramer, Blood	2009	630
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases Todd A. Carter, Lisa Wodicka, Neil P. Shah, Proceedings of the National Academy of Sciences	2005	554
Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680 Matthew A. Young, Neil P. Shah, Luke H. Chao, Cancer Research	2006	275
Identification of <i>N</i>-(5-<i>tert</i>-Butyl-isoxazol-3-yl)-<i>N</i>′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-<i>b</i>][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor Qi Chao, Kelly G. Sprankle, Robert M. Grotzfeld, Journal of Medicinal Chemistry Drug TargetAml PatientsPharmacotherapyChemical BiologyPharmaceutical Chemistry	2009	189
The Cyclase-associated Protein CAP as Regulator of Cell Polarity and cAMP Signaling in<i>Dictyostelium</i> Angelika A. Noegel, Rosemarie Blau‐Wasser, Hameeda Sultana, Molecular Biology of the Cell Adenylyl CyclaseMolecular BiologyCytoskeletonCamp SignalingCyclase-associated Protein Cap	2003	112
Clearance of Circulating Tumor Cells After Excision of Primary Colorectal Cancer Hitesh Patel, Nadia Le Marer, Richard Wharton, Annals of Surgery	2002	105
A conventional myosin motor drives neurite outgrowth Steven R. Wylie, Peijun Wu, Hitesh Patel, Proceedings of the National Academy of Sciences Muscle FunctionMolecular BiologyCytoskeletonMechanotransductionCellular Physiology	1998	102
Conservation of the regulated structure of folded myosin 2 in species separated by at least 600 million years of independent evolution Hyun Suk Jung, Stan A. Burgess, Neil Billington, Proceedings of the National Academy of Sciences Molecular Evolutionary EcologyMuscle FunctionMolecular BiologyRegulated StructureCytoskeleton	2008	90

Page 1